Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells

ABSTRACT The nephrotoxicity of polymyxins is a major dose-limiting factor for treatment of infections caused by multidrug-resistant Gram-negative pathogens. The mechanism(s) of polymyxin-induced nephrotoxicity is not clear. This study aimed to investigate polymyxin B-induced apoptosis in kidney proximal tubular cells. Polymyxin B-induced apoptosis in NRK-52E cells was examined by caspase activation, DNA breakage, and translocation of membrane phosphatidylserine using Red-VAD-FMK [Val-Ala-Asp(O-Me) fluoromethyl ketone] staining, a terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assay, and double staining with annexin V-propidium iodide (PI). The concentration dependence (50% effective concentration [EC50]) and time course for polymyxin B-induced apoptosis were measured in NRK-52E and HK-2 cells by fluorescence-activated cell sorting (FACS) with annexin V and PI. Polymyxin B-induced apoptosis in NRK-52E cells was confirmed by positive labeling from Red-VAD-FMK staining, TUNEL assay, and annexin V-PI double staining. The EC50 (95% confidence interval [CI]) of polymyxin B for the NRK-52E cells was 1.05 (0.91 to 1.22) mM and was 0.35 (0.29 to 0.42) mM for HK-2 cells. At lower concentrations of polymyxin B, minimal apoptosis was observed, followed by a sharp rise in the apoptotic index at higher concentrations in both cell lines. After treatment of NRK-52E cells with 2.0 mM polymyxin B, the percentage of apoptotic cells (mean ± standard deviation [SD]) was 10.9% ± 4.69% at 6 h and reached plateau (>80%) at 24 h, whereas treatment with 0.5 mM polymyxin B for 24 h led to 93.6% ± 5.57% of HK-2 cells in apoptosis. Understanding the mechanism of polymyxin B-induced apoptosis will provide important information for discovering less nephrotoxic polymyxin-like lipopeptides.

[1]  P. van der Smissen,et al.  Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. , 2005, Toxicology and applied pharmacology.

[2]  D. Calfee,et al.  Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. , 2012, The Journal of infection.

[3]  Jian Li,et al.  Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats , 2011, Antimicrobial Agents and Chemotherapy.

[4]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  H. Lassmann,et al.  Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  V. Toscano,et al.  Thyroid Hormone T3 Counteracts STZ Induced Diabetes in Mouse , 2011, PloS one.

[7]  J. Turnidge,et al.  fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. , 2010, The Journal of antimicrobial chemotherapy.

[8]  M. Falagas,et al.  Nephrotoxicity of intravenous colistin: a prospective evaluation. , 2005, International journal of antimicrobial agents.

[9]  Matthew E Falagas,et al.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Joshua D. Hartzell,et al.  Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  V. Cryns,et al.  Proteases to die for. , 1998, Genes & development.

[12]  E. Ozyilmaz,et al.  Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? , 2010, Intensive Care Medicine.

[13]  C. Landersdorfer,et al.  Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Seamus J. Martin,et al.  Phosphatidylserine Externalization during CD95-induced Apoptosis of Cells and Cytoplasts Requires ICE/CED-3 Protease Activity* , 1996, The Journal of Biological Chemistry.

[15]  Mirian Watanabe,et al.  Role of Heme Oxygenase-1 in Polymyxin B-Induced Nephrotoxicity in Rats , 2012, Antimicrobial Agents and Chemotherapy.

[16]  A. Zavascki,et al.  Polymyxin B versus other antimicrobials for the treatment of pseudomonas aeruginosa bacteraemia. , 2011, The Journal of antimicrobial chemotherapy.

[17]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[18]  A Forrest,et al.  Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients , 2011, Antimicrobial Agents and Chemotherapy.

[19]  J. Li,et al.  Pharmacokinetics of intravenous polymyxin B in critically ill patients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Nagata,et al.  Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 1998, Nature.

[21]  M. Falagas,et al.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies , 2006, Critical care.

[22]  J. López-Novoa,et al.  An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  R A Knight,et al.  Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.

[24]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[25]  E. Bae,et al.  Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats. , 2010, American journal of physiology. Renal physiology.

[26]  R. Nation,et al.  Colistin in the 21st century , 2009, Current opinion in infectious diseases.

[27]  G. Bridi,et al.  Recovery from colistimethate nephrotoxicity. , 1970, Annals of internal medicine.

[28]  M. Vaara,et al.  Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells , 2012, Peptides.

[29]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[30]  A. Wyllie Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.

[31]  Ming Hu,et al.  Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design , 2012, Antimicrobial Agents and Chemotherapy.

[32]  A. Zavascki,et al.  The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic. , 2010, The Journal of antimicrobial chemotherapy.

[33]  D. Graham,et al.  Effects of Large Doses of Colistin Sulphomethate Sodium on Renal Function , 1970, British medical journal.

[34]  J. Bartlett,et al.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  J. Persson,et al.  Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities. , 2009, Anticancer research.

[36]  D. Feingold,et al.  BASIS FOR THE SELECTIVITY OF ACTION OF THE POLYMYXIN ANTIBIOTICS ON CELL MEMBRANES * , 1974, Annals of the New York Academy of Sciences.

[37]  O. Kwon,et al.  Differential regulation of B/K protein expression in proximal and distal tubules of rat kidneys with ischemia-reperfusion injury. , 2007, American journal of physiology. Renal physiology.

[38]  V. Fadok,et al.  The role of phosphatidylserine in recognition of apoptotic cells by phagocytes , 1998, Cell Death and Differentiation.

[39]  Ding-ping Yang,et al.  Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis. , 2006, Pharmacological research.

[40]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[41]  J. Turnidge,et al.  Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration , 2003, Antimicrobial Agents and Chemotherapy.

[42]  G. Dong,et al.  The pathological role of Bax in cisplatin nephrotoxicity. , 2007, Kidney international.

[43]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[44]  J. Li,et al.  Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. , 2012, The Journal of antimicrobial chemotherapy.

[45]  K. Nitta,et al.  Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. , 2010, American journal of physiology. Renal physiology.

[46]  C. Kunin Binding of antibiotics to tissue homogenates. , 1970, The Journal of infectious diseases.

[47]  A. Schroit,et al.  Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. , 1998, The Journal of biological chemistry.

[48]  N. Won,et al.  MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. , 2005, Kidney international.

[49]  C. Landersdorfer,et al.  Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? , 2012, Diagnostic microbiology and infectious disease.

[50]  Tso‐Hsiao Chen,et al.  Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. , 2011, European journal of pharmacology.

[51]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[52]  M. Rosenberg,et al.  Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity. , 2002, American journal of physiology. Renal physiology.

[53]  Brian T. Tsuji,et al.  Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model , 2010, Antimicrobial Agents and Chemotherapy.

[54]  Dean P. Jones,et al.  Apoptosis: Cell death defined by caspase activation , 1999, Cell Death and Differentiation.

[55]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[56]  J. Turnidge,et al.  Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens , 2008, Antimicrobial Agents and Chemotherapy.

[57]  J. Turnidge,et al.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. , 2006, The Lancet. Infectious diseases.